NASOPHARYNGEAL HN007

Study #HN007

An Open Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Back To Clinical Trials